Saccoccia F, Angelucci F, Boumis G, Brunori M, Miele AE, Williams DL, Bellelli A
(d) cohort studies
Intestinal Hypoxia-Inducible Factor 2 Regulates Lactate Levels to Shape the Gut Microbiome and Alter Thermogenesis
the Danish cohort used other antidiabetic agents as the reference, while the Israeli study compared GLP-1RA users against non-users within the IBD-diabetes population, making cross-study comparison difficult
CagriSema (a combination of semaglutide and cagrilintide) is expected to seek regulatory approval in late 2025, and market overviews expect 1-2 new drugs entering the market every year for the next couple of years
Therefore, slow titration and following your healthcare providers dosage schedule can help you reduce the intensity and duration of the symptoms